- Report
- May 2024
- 180 Pages
Global
From €3961EUR$4,500USD£3,455GBP
- Report
- May 2024
- 185 Pages
Global
From €3961EUR$4,500USD£3,455GBP
- Report
- October 2024
- 200 Pages
Global
From €3301EUR$3,750USD£2,879GBP
- Report
- August 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,419GBP
- Report
- April 2023
- 111 Pages
Global
From €4181EUR$4,750USD£3,647GBP
- Report
- February 2024
- 203 Pages
Global
From €4181EUR$4,750USD£3,647GBP
- Report
- April 2023
- 112 Pages
Global
From €4181EUR$4,750USD£3,647GBP
- Report
- December 2024
- 160 Pages
Asia Pacific
From €3037EUR$3,450USD£2,649GBP
- Report
- August 2024
- 250 Pages
Global
From €3917EUR$4,450USD£3,417GBP
- Report
- December 2023
- 146 Pages
Global
From €3917EUR$4,450USD£3,417GBP
- Report
- August 2024
- 200 Pages
Global
From €4356EUR$4,949USD£3,800GBP
From €2455EUR$2,789USD£2,142GBP
- Report
- December 2023
- 247 Pages
Global
€4397EUR$4,995USD£3,835GBP
- Report
- January 2025
- 106 Pages
Global
From €3500EUR$4,259USD£3,160GBP

The Multiplex Sequencing market is a subset of the genomics industry that focuses on the sequencing of multiple DNA samples simultaneously. This technology is used to analyze the genetic makeup of a sample, such as a tumor, to identify mutations or other genetic changes. Multiplex sequencing is also used to study the genetic diversity of a population, to identify genetic markers associated with disease, and to develop new diagnostic tests.
Multiplex sequencing is a rapidly growing field, with many companies offering products and services. These include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, 10x Genomics, and BGI Genomics. Show Less Read more